Get along with yourself
Release time:
2021-06-11
On a sunny Sunday, the sun showed a long-lost smile. In the morning of early spring, the air is still cool. Although the sun is a little light, it can make people feel that it will be a sunny day.
What are you doing on such a fine day? Today, I don't want to go out for a stroll, clean up my room or go for an outing to get close to nature like the rest days in the past. I want to enjoy a relaxing time at home in peace. If you control this period of time to your heart's content, you really don't know what to do first. It's too free. I made a cup of tea first and picked up the harmonica that I wanted to play but felt I had no time to play. As a result, the beautiful melody made me completely intoxicated in the music. The cheerful rhythm of the music coupled with the clean and tidy environment at home made my mood more and more calm. In this situation I reluctantly, carefully appreciate this feeling. After a while, I opened the prose book that had been shelved for a long time and recited it aloud. In this period of time that belongs to oneself, do what you want, this is happiness. At this time, I feel that self-entertainment is more real, closer to myself, and more likely to let inspiration emerge.
The fast pace of life and changes in the world affect people's psychology all the time. When you are free, find out the most relaxing way to let your mind swim, how comfortable it is! I don't know if I can reach the state of leisurely and calm, but I can always relax my mood and make my heart feel at ease. Because being with nature and music is an important channel to arouse human emotions. In the afternoon of
, the sun shone on the balcony, making the balcony warm. I think I can't miss the opportunity of the sun to give the earth a warm time. So I moved a recliner and sat on the balcony full of golden sunshine. Lying on the chair with your eyes closed, let yourself receive the sunlight to the maximum extent, absorb the warmth of the sun, and gradually relax your body. I strongly felt the shrinking of my heart, the breathing of my lungs, and the thoughts of my brain shuttled like sunlight in the clouds, flickering and dimming. This is so good, I can't help writing this. I know that if I don't record it right away and get together, my daily affairs will stir up my current feeling more and more far, so that I will forget all about it.
In a busy life and work, finding time to spend with yourself is a great way to rest and recuperate. (Hong Zhiwei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31